✦ LIBER ✦

Increased CV risks with long-term celecoxib and rofecoxib

Book ID: 120849629
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 136 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615470-00056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rofecoxib, valdecoxib and celecoxib incr

Rofecoxib, valdecoxib and celecoxib increase risk of MI in rheumatic disease

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cardiovascular Events Associated with Lo

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan

✍ Dr Weng-Foung Huang, Fei-Yuan Hsiao, Yi-Wen Tsai, Yu-Wen Wen, Yaw-Tang Shih 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 116 KB

Rofecoxib and celecoxib users with prior

Rofecoxib and celecoxib users with prior MI at risk for another

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Greater long-term CV risk reduction with

Greater long-term CV risk reduction with intensive insulin therapy

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Fewer adverse effects with long-term cel

Fewer adverse effects with long-term celecoxib than ibuprofen and diclofenac

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Rofecoxib but not celecoxib increases sy

Rofecoxib but not celecoxib increases systolic blood pressure in hypertensive patients treated with ace inhibitors and beta-blockers

✍ White, William B.; Whelton, Andrew; Fort, John G. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 120 KB